Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim readout expected in the second half of 2025 —U.S. Food and ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger RNA—a prerequisite for protein synthesis in the cell. The poorly ...

Daniel Craig’s replacement as James Bond still hasn’t been announced (Pictures: Getty) James Bond speculation is a favourite pastime of both Brits and film fans alike, as we endure the ...

If you buy something, we may earn an affiliate commission. This is GQ's power ranking of the prime candidates to be the next James Bond, which is updated regularly — and will be until an ...

Gentlemen, rev your Aston Martins and start shaking those martinis, because a new James Bond is on the horizon. Menthol smoke has not yet started billowing out of MGM Studios – the traditional ...

Bond yields are flashing signs investors see an economic slowdown on the horizon. The yield on the two-year Treasury note dipped to its lowest level since October of last year this week. Investors ...

Another back injury for Jasprit Bumrah in the same spot where he had surgery "could be a career-ender" according to former New Zealand fast bowler Shane Bond, whose career ended prematurely due to ...

ARO-C3 showed a maximum mean C3 reduction of 89% and sustained reduction over 87% through 24 weeks in a Phase 1/2 study. The therapy reduced proteinuria, with a mean UPCR drop of 41% and a maximum ...